TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Endo International plc (NASDAQ:ENDP) Investor Investigation Concerning Potential Violations Of Securities Laws Announced

  • If you purchased shares of Endo International plc (NASDAQ:ENDP), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Endo International plc
Security
NASDAQ: ENDP

Summary

June 19, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Endo International plc (NASDAQ:ENDP) shares over potential securities laws violations by Endo International and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Endo International plc (NASDAQ:ENDP) concerning whether a series of statements by Endo International regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shares of Endo International plc (NASDAQ:ENDP) reached as high as $94.46 per share in April 2015.

On June 8, 2017, the U.S. Food and Drug Administration (the FDA) instructed Endo International plc to pull its powerful opioid painkiller Opana ER off the U.S. market. According to the FDA, Opanas high risk of abuse and potential to help spread HIV and hepatitis C necessitated its removal from the market.

Start Monitoring Your Investments